XML 40 R29.htm IDEA: XBRL DOCUMENT
v3.22.1

Financial Information for the Company and Its Subsidiaries | 3 Months Ended
--- | ---
Mar. 31, 2022
Organization Consolidation And Presentation Of Financial Statements [Abstract] |
Financial Information for the Company and Its Subsidiaries |
2 0. | Financial Information for the Company and Its Subsidiaries
The Company conducts substantially all of its business through its subsidiaries. The 5.500% Senior Notes and 5.000% Senior Notes are jointly and severally guaranteed on an unsecured senior basis by all of the Company’s subsidiaries that guarantee the Company’s obligations under the New Credit Facility. Summarized financial information is presented below is consistent with the condensed consolidated financial statements of the Company, except transactions between combining entities have been eliminated. Financial information for the combined non-guarantor entities has been excluded. Presented below is condensed financial information for the combined wholly-owned subsidiary guarantors at March 31, 2022 and December 31, 2021, and for the three months ended March 31, 2022. Summarized balance sheet information (in thousands):
|  | March 31, 2022 |  |  | December 31, 2021 |
Current assets |  | $ | 453,748 |  |  | $ | 422,113 |
Property and equipment, net |  |  | 1,534,615 |  |  |  | 1,525,569 |
Goodwill |  |  | 2,087,700 |  |  |  | 2,086,978 |
Total noncurrent assets |  |  | 3,908,572 |  |  |  | 3,893,087 |
Current liabilities |  |  | 388,834 |  |  |  | 385,044 |
Long-term debt |  |  | 1,447,937 |  |  |  | 1,460,046 |
Total noncurrent liabilities |  |  | 1,753,630 |  |  |  | 1,752,271 |
Redeemable noncontrolling interests |  |  | — |  |  |  | — |
Total equity |  |  | 2,219,856 |  |  |  | 2,177,885 |
Summarized operating results information (in thousands):
|  | Three Months Ended March 31, 2022 |
Revenue |  | $ | 569,806 |
Income before income taxes |  |  | 72,712 |
Net income |  |  | 56,687 |
Net income attributable to Acadia Healthcare Company, Inc. |  |  | 56,687 |

X
- Definition The entire disclosure for condensed financial statements. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph d -Subparagraph 4 -Subsection 10 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph c -Subparagraph 4 -Subsection 10 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph e -Subparagraph 4 -Subsection 10 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 12 -Paragraph a -Subsection 04 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph f -Subparagraph 4 -Subsection 10 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690 + Details
Name: | srt_CondensedFinancialStatementsTextBlock
Namespace Prefix: | srt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration